Will the manufacturer of Tylenol sue the Trump administration this year?
RFK Jr gives Kenvue a throbbing headache.
A Lawsuit Nobody Wants
The White House has decided to target Tylenol (against medical advice, as it were). A Kalshi market is trying to predict whether Kenvue, the maker of Tylenol, will sue the government this year. The rules pay on any Kenvue suit against an administration entity or official, and pre-trial action like discovery counts.
Follow the market: Will the manufacturer of Tylenol sue the Trump administration this year? on Kalshi
What’s In A Label?
Health Secretary Robert F Kennedy Jr has informed the country an FDA warning is coming that links Tylenol use in pregnancy to autism, with guidance that discourages use except in urgent cases. Medical agencies pushed back, with the FDA itself still calling acetaminophen the safest option in pregnancy. Kenvue said it “strongly disagrees” and there is no causal evidence. In the chaos after the announcement, the stock first dipped then rebounded.
The administration’s science is thin where this issue has been litigated. A federal judge found testimony “unreliable” from a key epidemiologist in a previous round of Tylenol autism suits. Multiple experts say the evidence is inconsistent and not causal, and a large recent study found no association. But to think that empirical evidence is needed for a policy position is to ignore the way this administration operates.